Salman M Hyder Selected Research

Progestins (Progestagens)

1/2017	Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.
1/2017	Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells.
2/2016	Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
1/2015	Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
1/2013	The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
1/2013	Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
8/2012	Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
1/2012	Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.
8/2011	Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
9/2010	Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salman M Hyder Research Topics

Disease

38	Neoplasms (Cancer) 02/2022 - 07/2002
36	Breast Neoplasms (Breast Cancer) 02/2022 - 07/2002
8	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2005
3	Triple Negative Breast Neoplasms 01/2022 - 01/2017
3	Carcinogenesis 02/2016 - 09/2010
3	Breast Diseases (Breast Disease) 08/2012 - 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Hyperplasia 08/2011
1	Ischemia 01/2011
1	Lymphatic Metastasis 09/2010

Drug/Important Bio-Agent (IBA)

25	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2002
25	Progestins (Progestagens)IBA 01/2017 - 07/2002
22	Estrogens (Estrogen)FDA Link 01/2019 - 04/2004
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
15	Hormones (Hormone)IBA 02/2022 - 09/2006
15	Progesterone CongenersIBA 01/2017 - 02/2005
12	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2017 - 10/2007
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 02/2005
7	Estrogen ReceptorsIBA 02/2022 - 04/2004
6	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 04/2011 - 10/2007
5	CholesterolIBA 02/2022 - 07/2014
5	EnzymesIBA 02/2022 - 07/2014
5	Ro 48-8071IBA 02/2022 - 04/2011
5	LigandsIBA 02/2022 - 02/2005
5	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
5	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2015 - 05/2008
5	Fulvestrant (Faslodex)FDA Link 09/2009 - 07/2002
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006 - 07/2002
4	Norethindrone (Norethisterone)FDA LinkGeneric 01/2017 - 09/2010
4	FlavonoidsIBA 01/2015 - 08/2011
4	Messenger RNA (mRNA)IBA 10/2014 - 02/2005
4	ApigeninIBA 01/2013 - 09/2010
4	Progesterone FDA LinkGeneric 09/2010 - 07/2002
3	FumaratesIBA 02/2022 - 07/2014
3	lanosterol synthaseIBA 02/2022 - 07/2014
3	LuteolinIBA 01/2017 - 01/2015
3	SteroidsIBA 01/2016 - 09/2006
3	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2013 - 09/2010
3	Mifepristone (RU 486)FDA Link 09/2010 - 07/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 09/2010 - 04/2004
3	anthraceneIBA 01/2010 - 07/2006
3	Thrombospondin 1IBA 09/2009 - 04/2004
2	lissamine rhodamine B (sulforhodamine B)IBA 02/2022 - 07/2014
2	Estrogen Receptor betaIBA 02/2022 - 10/2007
2	PhosphatidylserinesIBA 01/2019 - 01/2018
2	eprenetapoptIBA 01/2019 - 01/2018
2	Aldehyde DehydrogenaseIBA 01/2017 - 01/2015
2	Biological ProductsIBA 10/2014 - 09/2010
2	Norgestrel (DL-Norgestrel)FDA LinkGeneric 09/2010 - 09/2010
2	CurcuminIBA 01/2010 - 05/2008
2	Conditioned Culture MediaIBA 09/2009 - 08/2005
2	Angiogenesis InhibitorsIBA 10/2007 - 07/2006
2	progesterone receptor BIBA 12/2005 - 03/2004
2	Tamoxifen FDA LinkGeneric 12/2005 - 03/2004
1	liquiritigeninIBA 02/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019
1	Tumor Suppressor Protein p53IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	ImmunosorbentsIBA 01/2015
1	AndrogensIBA 10/2014
1	Simvastatin (Zocor)FDA LinkGeneric 07/2014
1	Fluvastatin FDA Link 07/2014
1	3- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazoleIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	Phytoestrogens (Phytoestrogen)IBA 01/2013
1	RANK LigandIBA 08/2012
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 12/2011
1	Complement System Proteins (Complement)IBA 12/2011
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Therapeutic UsesIBA 01/2011
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2010
1	flavoneIBA 09/2010
1	turmeric extractIBA 01/2010
1	Extracellular Matrix ProteinsIBA 09/2009
1	Cysteine (L-Cysteine)FDA Link 03/2009
1	Angiogenic ProteinsIBA 03/2009
1	PolyphenolsIBA 05/2008
1	matrigelIBA 10/2007
1	Estrogen Receptor alphaIBA 10/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2005
1	Transcription Factors (Transcription Factor)IBA 02/2005
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2005
1	Estrogen Receptor Modulators (Antiestrogen)IBA 07/2002

Therapy/Procedure

21	Therapeutics 02/2022 - 03/2004
9	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2017 - 08/2005
3	Contraception (Birth Control) 09/2010 - 08/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
2	Aftercare (After-Treatment) 02/2016 - 01/2011
1	Castration 01/2016
1	Injections 09/2010
1	Estrogen Replacement Therapy 10/2007